Pages

▼
Showing posts with label Haller. Show all posts
Showing posts with label Haller. Show all posts
Sunday, May 20, 2018

Results from a Phase-II ATG and GCSF Combination Trial

›
I'm embarrassed about this blog posting, because it is very late.  It reports on news announced about 18 months ago.  I was digging thr...
1 comment:
Sunday, April 19, 2015

ATG and GCSF Combination Starts a Phase-II Trial

›
ATG is Anti-Thymocyte Globulin, a biological agent used to lower immune reactions. GCSF is Granulocyte Colony-Stimulating Factor, a biolog...
3 comments:
Tuesday, September 25, 2012

Possible Cures for Type-1 in the News (late Sept-2012)

›
Prochymal Failed Phase-II Trials I missed this, when it was published back in May, but luckily Kelly Close (of Close Concerns, who publis...
Monday, August 13, 2012

Possible Cures for Type-1 in the News (early Aug-2012)

›
Prologue: Why Completing Enrollment is an Important Milestone for Clinical Trials For two reasons.  First, because at that point it is p...
7 comments:
Tuesday, August 31, 2010

Possible Cures for Type-1 in the News (late-Aug)

›
  GCSF (Neulasta/Pegfilgrastim) Starts a Phase-I Clinical Trial This is straight forward trial where GCSF is given to people in the hone...
1 comment:
Saturday, August 14, 2010

ATG + GCSF Starts a Phase-I Clinical Trial

›
ATG + GCSF Starts a Phase-I Clinical Trial This is a very interesting study, which is why I'm giving it, it's own blog posting.  ...
4 comments:
Thursday, May 21, 2009

Haller Cord Blood trial, results from Phase-I and Starting Phase-II

›
Haller at University of Florida is running a research program to transfuse into honeymoon diabetics their own (previously frozen) umbilical ...